An innovative NIMH-funded trial shows that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders.
Source: NIH
Science News » Fast-Fail Trial Shows New Approach to Identifying Brain Targets for Clinical Treatments
Published in Psychiatric
More from PsychiatricMore posts in Psychiatric »
Be First to Comment